99. Deputy Louise O'Reilly asked the Minister for Health his views on the need for a dedicated policy for the approval and reimbursement of orphan drugs for rare diseases, which is separate to the current policy, in view of the fact that the national rare disease plan for Ireland 2014-2018 recommended the bringing forward of appropriate decision criteria for the reimbursement of orphan rare medicines and technologies; and if he will make a statement on the matter. [48114/17]

Summary

99. Deputy Louise O'Reilly asked the Minister for Health his views on the need for a dedicated policy for the approval and reimbursement of orphan drugs for rare diseases, which is separate to the current policy, in view of the fact that the national rare disease plan for Ireland 2014-2018 recommended the bringing forward of appropriate decision criteria for the reimbursement of orphan rare medicines and technologies; and if he will make a statement on the matter. [48114/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Reimbursement

  xml · EN · 15 November 2017

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.